c-Met activation can be ligand-dependent or -independent and is associated with androgen receptor (AR)-deficient castration-resistant prostate cancer (CRPC; Verras et al. 2007) and AR-negative PCa stem cells (van Leenders et al. 2011). This evidence concerns the gene AR and posterior cortical atrophy.